Back to Browse Journals » International Journal of Women's Health » Volume 5

Maternal mortality in rural South Africa: the impact of case definition on levels and trends

Authors Garenne M, Kahn K, Collinson MA, Gómez-Olivé FX, Tollman S

Published Date August 2013 Volume 2013:5 Pages 457—463


Received 30 March 2013, Accepted 11 May 2013, Published 6 August 2013

Video presented by Kathleen Kahn.

Views: 117

Michel Garenne,1–3 Kathleen Kahn,1,4,5 Mark A Collinson,1,4,5 F Xavier Gómez-Olivé,1,5 Stephen Tollman1,4,5

MRC/Wits Rural Public Health and Health Transitions Research Unit (Agincourt), School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; 2Institut Pasteur, Epidémiologie des Maladies Emergentes, Paris, France; 3Institut de Recherche pour le Développement, UMI Résiliences, Centre Ile de France, Bondy, France; 4Centre for Global Health Research, Umeå University, Umeå, Sweden; 5INDEPTH Network, East Legon, Accra, Ghana

Background: Uncertainty in the levels of global maternal mortality reflects data deficiencies, as well as differences in methods and definitions. This study presents levels and trends in maternal mortality in Agincourt, a rural subdistrict of South Africa, under long-term health and sociodemographic surveillance.
Methods: All deaths of women aged 15 years–49 years occurring in the study area between 1992 and 2010 were investigated, and causes of death were assessed by verbal autopsy. Two case definitions were used: “obstetrical” (direct) causes, defined as deaths caused by conditions listed under O00-O95 in International Classification of Diseases-10; and “pregnancy-related deaths”, defined as any death occurring during the maternal risk period (pregnancy, delivery, 6 weeks postpartum), irrespective of cause.
Results: The case definition had a major impact on levels and trends in maternal mortality. The obstetric mortality ratio averaged 185 per 100,000 live births over the period (60 deaths), whereas the pregnancy-related mortality ratio averaged 423 per 100,000 live births (137 deaths). Results from both calculations increased over the period, with a peak around 2006, followed by a decline coincident with the national roll-out of Prevention of Mother-to-Child Transmission of HIV and antiretroviral treatment programs. Mortality increase from direct causes was mainly due to hypertension or sepsis. Mortality increase from other causes was primarily due to the rise in deaths from HIV/AIDS and pulmonary tuberculosis.
Conclusion: These trends underline the major fluctuations induced by emerging infectious diseases in South Africa, a country undergoing rapid and complex health transitions. Findings also pose questions about the most appropriate case definition for maternal mortality and emphasize the need for a consistent definition in order to better monitor and compare trends over time and across settings.

Keywords: maternal mortality, direct causes, pregnancy related deaths, Agincourt, South Africa

Download Article [PDF] View Full Text [HTML] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at:

Other article by this author:

A framework for analyzing sex-selective abortion: the example of changing sex ratios in Southern Caucasus

Hohmann SA, Lefèvre CA, Garenne ML

International Journal of Women's Health 2014, 6:889-897

Published Date: 20 October 2014

Readers of this article also read:

Neuromodulation and antenatal depression: a review

Kim DR, Snell JL, Ewing GC, O’Reardon J

Neuropsychiatric Disease and Treatment 2015, 11:975-982

Published Date: 7 April 2015

Multifaceted prospects of nanocomposites for cardiovascular grafts and stents

Vellayappan MV, Balaji A, Subramanian AP, John AA, Jaganathan SK, Murugesan S, Supriyanto E, Yusof M

International Journal of Nanomedicine 2015, 10:2785-2803

Published Date: 7 April 2015

Maternal and neonatal tetanus elimination: from protecting women and newborns to protecting all

Khan R, Vandelaer J, Yakubu A, Raza AA, Zulu F

International Journal of Women's Health 2015, 7:171-180

Published Date: 3 February 2015

Comorbidity and health-related quality of life in patients with severe chronic obstructive pulmonary disease attending Swedish secondary care units

Sundh J, Johansson G, Larsson K, Lindén A, Löfdahl CG, Janson C, Sandström T

International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:173-183

Published Date: 22 January 2015

Managing comorbidities in COPD

Hillas G, Perlikos F, Tsiligianni I, Tzanakis N

International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:95-109

Published Date: 7 January 2015

Letter to the editor

Atchison DA, Hartwig A

Clinical Ophthalmology 2013, 7:1603-1604

Published Date: 8 August 2013

Nonselective ß-blocker propranolol for orbital and periorbital hemangiomas in infants: a new first-line of treatment?

El-Essawy R, Galal R, Abdelbaki S

Clinical Ophthalmology 2011, 5:1639-1644

Published Date: 18 November 2011

Nanocarriers as pulmonary drug delivery systems to treat and to diagnose respiratory and non respiratory diseases

Malgorzata Smola, Thierry Vandamme, Adam Sokolowski

International Journal of Nanomedicine 2008, 3:1-19

Published Date: 16 March 2008